Ülke: İrlanda
Dil: İngilizce
Kaynak: HPRA (Health Products Regulatory Authority)
SALMETEROL XINAFOATE; Fluticasone propionate
GlaxoSmithKline (Ireland) Limited
R03AK06
SALMETEROL XINAFOATE; Fluticasone propionate
25/250 microgram(s)/dose
Pressurised inhalation, suspension
Product subject to prescription which may be renewed (B)
salmeterol and fluticasone
Marketed
2001-02-21
1 PACKAGE LEAFLET: INFORMATION FOR THE USER Seretide Evohaler 25 microgram/50 microgram per metered dose pressurised inhalation, suspension Seretide Evohaler 25 microgram/125 microgram per metered dose pressurised inhalation, suspension Seretide Evohaler 25 microgram/250 microgram per metered dose pressurised inhalation, suspension [To be completed nationally] salmeterol/fluticasone propionate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET : 1. What Seretide is and what it is used for 2. What you need to know before you use Seretide 3. How to use Seretide 4. Possible side effects 5. How to store Seretide 6. Contents of the pack and other information 1. WHAT SERETIDE IS AND WHAT IT IS USED FOR Seretide contains two medicines, salmeterol and fluticasone propionate: • Salmeterol is a long-acting bronchodilator. Bronchodilators help the airways in the lungs to stay open. This makes it easier for air to get in and out. The effects last for at least 12 hours. • Fluticasone propionate is a corticosteroid which reduces swelling and irritation in the lungs. The doctor has prescribed this medicine to help prevent breathing problems such as asthma. You must use Seretide every day as directed by your doctor. This will make sure that it works properly in controlling your asthma. SERETIDE HELPS TO STOP BREATHLESSNESS AND WHEEZINESS COMING ON. HOWEVER SERETIDE SHOULD NOT BE USED TO RELIEVE A SUDDEN ATTACK OF BREATHLESSNESS OR WHEEZING. IF THIS HAPPENS YOU NEED TO USE A FAST-ACTING ‘RELIEVER’ (‘RESCUE’) INH Belgenin tamamını okuyun
Health Products Regulatory Authority 16 October 2023 CRN00DTMF Page 1 of 14 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Seretide 250 Evohaler 25 microgram/250 microgram/dose pressurised inhalation, suspension 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each metered dose (ex valve) contains: 25 micrograms of salmeterol (as salmeterol xinafoate)and 50, 125 or 250 micrograms of fluticasone propionate. This is equivalent to a delivered dose (ex actuator) of 21 micrograms of salmeterol and 44, 110 or 220 micrograms of fluticasone propionate. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Pressurised inhalation, suspension. The canister contains a white to off white suspension. The canisters are fitted into purple plastic actuators incorporating an atomising orifice and fitted with dustcaps. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Seretide is indicated in the regular treatment of asthma where use of a combination product (long-acting β 2 agonist and inhaled corticosteroid) is appropriate: ● patients not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β 2 agonist or ● patients already adequately controlled on both inhaled corticosteroid and long-acting β 2 agonist 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Posology_ Route of administration: Inhalation use. Patients should be made aware that Seretide Evohaler must be used daily for optimum benefit, even when asymptomatic. Patients should be regularly reassessed by a doctor, so that the strength of Seretide they are receiving remains optimal and is only changed on medical advice. THE DOSE SHOULD BE TITRATED TO THE LOWEST DOSE AT WHICH EFFECTIVE CONTROL OF SYMPTOMS IS MAINTAINED. WHERE THE CONTROL OF SYMPTOMS IS MAINTAINED WITH THE LOWEST STRENGTH OF THE COMBINATION GIVEN TWICE DAILY THEN THE NEXT STEPCOULD INCLUDE A TEST OF INHALED CORTICOSTEROID ALONE. As an alternative, patients requiring a long- acting β2 agonist could be titrated to Seretide given once daily i Belgenin tamamını okuyun